No headlines found.
No press releases found.
No news found.
Bristol-Myers Squibb Company Celegne Contingent Value Rights trades on the stock market under the symbol CELG^.
As of December 18, 2025, CELG^ stock price was flat at $0.04 with million shares trading.
CELG^ has a beta of -1.19, meaning it tends to be less sensitive to market movements. CELG^ has a correlation of 0.02 to the broad based SPY ETF.
CELG^ has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, CELG^ traded as high as $.17 and as low as $.02.
CELG^ has underperformed the market in the last year with a price return of -10.0% while the SPY ETF gained +13.1%. CELG^ has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -3.7% and -3.4%, respectively, while the SPY returned +2.9% and -1.1%, respectively.
CELG^ support price is $.03 and resistance is $.05 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CELG^ shares will trade within this expected range on the day.
